Walleye Trading’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,721
Closed -$24K 6281
2021
Q3
$24K Buy
+6,721
New +$25.4K ﹤0.01% 4835
2021
Q1
Sell
-10,102
Closed -$42K 5714
2020
Q4
$42K Buy
+10,102
New +$38.9K ﹤0.01% 4235
2020
Q2
Sell
-17,885
Closed -$68K 4882
2020
Q1
$68K Buy
+17,885
New +$87.9K ﹤0.01% 3316
2018
Q4
Sell
-7,000
Closed -$20K 5893
2018
Q3
$20K Buy
+7,000
New +$19.6K ﹤0.01% 4848
2017
Q3
Sell
-32,000
Closed -$90 4962
2017
Q2
$90 Buy
32,000
+31,000
+3,100% +$65.4K ﹤0.01% 3606
2017
Q1
$2 Buy
+1,000
New +$1.93K ﹤0.01% 4560

Other funds holding BDSI

Walleye Trading's BDSI Position: Q4 2021 in Review

Walleye Trading sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 6,721 shares — an estimated $24K sold.

Walleye Trading first reported a position in BDSI in Q1 2017 and held it in 6 quarters. The position peaked at $68K in Q1 2020. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

  • Walleye Trading reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
  • Walleye Trading sold 6,721 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $24K.
  • Walleye Trading first reported a position in BioDelivery Sciences International, Inc. in Q1 2017 and held it in 6 quarters.
  • Walleye Trading's BioDelivery Sciences International, Inc. position peaked at $68K in Q1 2020.
  • 156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.